apitolisib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for apitolisib, covering 2023-09-14 to 2023-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy [Phase 1, Phase 2]